Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer

Supportive Care in Cancer

Volumn 1, Issue 1, 1993, Pages 57-58

  Stiefel, Friedrich ^a   Morant, Rudolf ^a  

^a Palliative Care Unit   (Switzerland)

Author keywords

Obstructive ileus in advanced cancer; Somatostatin

Indexed keywords

ANTI INFLAMMATORY AGENTS, NON STEROIDAL; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOSTATIN; VAPREOTIDE;

AGED; ARTICLE; CANCER INVASION; CASE REPORT; DUODENUM TUMOR; DUODENUM ULCER; FEMALE; HUMAN; IATROGENIC DISEASE; INTESTINE OBSTRUCTION; PALLIATIVE THERAPY; PANCREAS TUMOR; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CASE REPORT; DUODENAL NEOPLASMS; DUODENAL ULCER; FEMALE; HUMAN; INTESTINAL OBSTRUCTION; NEOPLASM INVASIVENESS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; SOMATOSTATIN;

EID: 0027341783     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/BF00326640     Document Type: Article

References (4)

1. Somatostatin as adjuvant therapy in the management of obstructive ileus
2. Comparison of somatostatin and its highly potent hexa-and octapeptide analogs on exocrine and endocrine pancreatic secretion
3. Adjunctive treatment of intestinal obstruction with somatostatin